| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707350 | Oral Oncology | 2018 | 9 Pages |
Abstract
SCRT is mainly beneficial in stage II NPC, leading to better DMFS and/or equivalent acute hematological toxicities compared to CCRT/IMRT alone. CCRT is still the best choice for low-risk stage III-IV NPC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Cheng Xu, Rui Sun, Ling-Long Tang, Lei Chen, Wen-Fei Li, Yan-Ping Mao, Guan-Qun Zhou, Rui Guo, Ai-Hua Lin, Ying Sun, Jun Ma, Wei-Han Hu,